Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
"Our 18 to 21% RRR is actually well ahead of many other cardiovascular disease drugs. I know this is not an apples to apples comparison...but take it for what it is."
Yes, 18-21% is really good, especially in the high-risk diabetic low-HDL recent ACS patient population. Too bad BETonMACE was underpowered to hit w/ statistical significance at this lower RRR.
